What Clinical Evidence Shows About Tirzepatide and Period Changes Clinical trials of tirzepatide (SURMOUNT series) documented menstrual abnormalities in a small percentage of participants, most commonly amenorrhea (absent periods) or oligomenorrhea (infrequent periods)
As a company at the forefront of supplying high-purity peptides for laboratory settings, we've seen a dramatic surge in interest surrounding its potential
Meanwhile, some in the medical community believe the unfettered use of peptides, often guided by a colorful array of YouTubers, represents one of the most dangerous frontiers in medicine today as it leaves the patient to also be the doctor, the nurse, and the pharmacist all in one
However, it has not specified a timeline
Gong, C., Yang, Y., Chen, M